AMANDA HARRIS: Open Payments
NPI 1043746936 · GULFPORT, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$941 in 46 payments from 17 companies in 2025. Trend: 2023 $1,062 · 2024 $1,499 · 2025 $941
Food & beverage: $941
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 15 | $175 |
| Organon LLC | 2 | $137 |
| Galderma Laboratories, L.P. | 4 | $85 |
| Janssen Biotech, Inc. | 3 | $79 |
| E.R. Squibb & Sons, L.L.C. | 3 | $76 |
| UCB, Inc. | 3 | $73 |
| Lilly USA, LLC | 3 | $67 |
| GENZYME CORPORATION | 2 | $48 |
| Novartis Pharmaceuticals Corporation | 2 | $42 |
| Botanix SB Inc | 2 | $28 |
Products named: SKYRIZI, TREMFYA, Sotyktu, Bimzelx, EBGLYSS, NEMLUVIO, DUPIXENT, RINVOQ.
Industry payments across MS — which companies pay providers there.
